Healthcare -
Biotechnology - NASDAQ - US
$ 4.585
-1.98 %
$ 282 M
Market Cap
-4.55
P/E
GLUE - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities GLUE - Monte Rosa Therapeutics, Inc.
-44.5 M
LAST VALUE
54.97%
2 YEAR CAGR
-100.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR